Literature DB >> 8608264

About the t(8;13)(p11;q12) clinico-pathologic entity.

L Michaux, C Mecucci, E R Pereira Velloso, J Dierlamm, A Criel, A Louwagie, A van Orshoven, H van den Berghe.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8608264

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

1.  Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1.

Authors:  Barbara J Bain
Journal:  Haematologica       Date:  2010-05       Impact factor: 9.941

2.  Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13).

Authors:  C Popovici; J Adélaïde; V Ollendorff; M Chaffanet; G Guasch; M Jacrot; D Leroux; D Birnbaum; M J Pébusque
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

Review 3.  [The 8p11 myeloproliferative syndrome].

Authors:  A Reither; R Hehlmann; J M Goldman; N C Cross
Journal:  Med Klin (Munich)       Date:  1999-04-15

4.  The 8p11 myeloproliferative syndrome: review of literature and an illustrative case report.

Authors:  Ami Goradia; Michael Bayerl; Dennis Cornfield
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.